Frontlight ResearchEarly access
Peripheral artery disease trials in Israel
2 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in IsraelEfficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
- Where
- Haifa, Jerusalem, Kfar Saba, Petah Tikva
- Age
- 18 years and over
- People
- 1,205 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07223593 · EU 2025-523283-21-00 - Phase 2/3Taking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Afula, Ashkelon, Haifa, Holon, Nahariya, Petah Tikva, Ramat Gan, Rehovot, Safed, Tel Aviv, Tiberias
- Age
- 18 years and over
- People
- 3,110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00